IRC
RVMD icon

Investors Research Corp’s Revolution Medicines RVMD Stock Holding History

Investors Research Corp’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-35
Closed -$834 – 1153
2022
Q4 		$834 Hold
35
– – ﹤0.01% 1058
2022
Q3 		$1K Hold
35
– – ﹤0.01% 1051
2022
Q2 		$1K Hold
35
– – ﹤0.01% 1043
2022
Q1 		$1K Hold
35
– – ﹤0.01% 990
2021
Q4 		$1K Hold
35
– – ﹤0.01% 953
2021
Q3 		$1K Hold
35
– – ﹤0.01% 963
2021
Q2 		$1K Hold
35
– – ﹤0.01% 949
2021
Q1 		$2K Hold
35
– – ﹤0.01% 904
2020
Q4 		$1K Buy
35
+15
+75% +$593 ﹤0.01% 1043
2020
Q3 		$1K Buy
+20
New +$554 ﹤0.01% 1056

Other funds holding RVMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Investors Research Corp's RVMD Position: Q1 2023 in Review

Investors Research Corp sold out of Revolution Medicines (RVMD) in Q1 2023, closing a stake of 35 shares — an estimated $834 sold.

Investors Research Corp first reported a position in RVMD in Q3 2020 and held it in 10 quarters. The position peaked at $2K in Q1 2021. 152 funds tracked by Wall St. Rank hold RVMD as of Q1 2023.

  • Investors Research Corp reported no remaining Revolution Medicines position as of Q1 2023 after selling out during the quarter.
  • Investors Research Corp sold 35 Revolution Medicines shares in Q1 2023, an estimated $834.
  • Investors Research Corp first reported a position in Revolution Medicines in Q3 2020 and held it in 10 quarters.
  • Investors Research Corp's Revolution Medicines position peaked at $2K in Q1 2021.
  • 152 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2023.

Based on Investors Research Corp's 13F filing for Q1 2023, filed 11 May 2023.